Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.

Hematological oncology - 1 Aug 2023

Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fang

Abstract excerpt

Myelodysplastic syndromes (MDS) are a group of clinically and genetically diverse diseases that impose patients with an increased risk of leukemic transformation. While MDS is a disease of the elderly, the interplay between aging and molecular profiles is not fully understood, especially in the Asian population. Thus, we compared the genetic landscape between younger and older patients in a cohort of 698 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myelodysplastic Syndromes

Share to Prognosis

Share to Survival Analysis

Source

Identifiers

PMID: 36420747
DOI: 10.1002/hon.3109

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.PMID 36420747Read ↗

Genetic alterations and their clinical implications in older patients with acute myeloid leukemia.Semantic proximity Read ↗

Comparison of gene mutation spectra in younger and older Chinese acute myeloid leukemia patients and its prognostic value.Semantic proximity Read ↗

Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML.Semantic proximity Read ↗

Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes.Semantic proximity Read ↗

Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.Semantic proximity Read ↗

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.Semantic proximity Read ↗

Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patientsSemantic proximity Read ↗

Aging and comprehensive molecular profiling in acute myeloid leukemia.Semantic proximity Read ↗

De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features.Semantic proximity Read ↗

Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.Semantic proximity Read ↗

Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older.Semantic proximity Read ↗

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.